Next Article in Journal
Electrochemical Study of Bromide in the Presence of 1,3-Indandione. Application to the Electrochemical Synthesis of Bromo Derivatives of 1,3-Indandione
Previous Article in Journal
Nitration Of Phenols Under Mild And Heterogeneous Conditions
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Heterocyclic o-Aminonitriles: Preparation of Pyrazolo[3,4-d]-pyrimidines with Modification of the Substituents at the 1- Position

Chemistry Department, Faculty of Science-Girls College 838, Dammam 31113, Saudi Arabia
*
Author to whom correspondence should be addressed.
Molecules 2001, 6(7), 621-638; https://doi.org/10.3390/60700621
Submission received: 19 February 2001 / Revised: 4 June 2001 / Accepted: 7 June 2001 / Published: 30 June 2001

Abstract

:
Novel 1-[6-(p-tolyl) pyridazin-3-yl]pyrazole-o-aminonitriles (3a-c) were formed using 3-hydrazino-6-(p-tolyl)pyridazine (2) and ketene S,S-acetals (1a), S,N-acetals (1b) or tetracyanoethylene (1c). The pyrazole-o-aminonitriles (3a-c) were in turn used as precursors for the preparation of previously unreported 1-[6-(p-tolyl)-pyridazin-3-yl]pyrazolo[3,4-d]pyrimidines (8, 9, 13-20) and 7-[6-( p-tolyl) pyridazin-3-yl]2-arylpyrazolo[3,4-d]1,2,4-triazolo[5,1-f]pyrimidines (10-12) which are expected to possess considerable chemical and pharmacological activities.

Introduction

Pyrazolo[3,4-d]pyrimidines are of considerable chemical and pharmacological importance as purine analogs [1,2,3]. Various compounds with related structures also possess anti-tumor and anti-leukemia activities [4,5]. On the other hand, substituted pyridazines are often used in medicine thanks to their pronounced bactericidal and fungicidal effects [6]. As a continuation of our work on azoloazines [7], we aimed to incorporate the pyridazine moiety into the 1-position of the pyrazolo[3,4-d]pyrimidine ring system to thus obtain a new heterocyclic system which is expected to possess notable chemical and pharmacological activities.

Results and Discussion

The key pyrazole-o-aminonitrile precursors (3a-c) were prepared by the reaction of 3-hydrazino-6-(p-tolyl)pyridazine (2) [8] with ketene S,S- and S,N-acetals (1a,b) which were prepared using Phase Transfer Catalysis (PTC) [9], or tetracyanoethylene (1c).
Scheme 1.
Scheme 1.
Molecules 06 00621 g002
The reaction sequence shown in Scheme 1 yielded only one product (3) instead of a mixture of the two possible isomeric pyrazole-o-aminonitriles 3 and 4. This fact was confirmed by the several strategies. First, by using the technique of Hecht et al. [10], who found it was possible to differentiate between the isomeric pyrazoles 5 and 6 based on their different reactivity; thus, treatment of 6 with acetic anhydride in pyridine at room temperature afforded the corresponding N-acetyl derivative, but pyrazole 5 did not form the corresponding derivative under the same conditions, although it did form at 50-60°C (Scheme 2).
Scheme 2.
Scheme 2.
Molecules 06 00621 g003
By analogy with the results of Hecht et al, when our product was treated with acetic anhydride, it formed the corresponding acetyl derivative only at higher temperatures and not at room temperature, due to the electronic and steric factors of the substituents (Ar and CN). Secondly, only one spot was obtained in TLC. Third, the structure of the product was identified as that of 3 on the basis of the X-ray crystal structure analysis, which confirmed the substituted nitrogen of the pyrazole ring is adjacent to the amino group (Figure 1). Finally, the structural assignment of 3 was also based on spectral evidence (IR, 1H-NMR, 13C-NMR and Mass spectrometry, while COSY- 2D experiments indicated the (C-H) and (H-H) correlations).
Fig. 1. Single-crystal X-ray analysis. ORTEP view of 3a showing the atom numbering scheme,
Fig. 1. Single-crystal X-ray analysis. ORTEP view of 3a showing the atom numbering scheme,
Molecules 06 00621 g001
The above mentioned pyrazoles were used as intermediates for the synthesis of new pyrazolo[3,4-d]pyrimidines because they contain the ß-enaminonitrile moiety which is well known to be highly reactive. Thus, condensation of 3a-c with triethylorthoformate in refluxing acetic anhydride afforded the intermediate ethoxymethyleneamino derivatives (7a-c) (Scheme 3), which were isolated and used without purification in the next step. Treatment of 7a-c with cold aqueous alcoholic ammonia yielded 4-aminopyrazolo[3,4-d]pyrimidines (8a-c). The IR spectrum of 8a,b displayed no absorption for the cyano group. We also attempted a direct synthesis of compounds 8a-c by treating pyrazoles 3a-c with formamide. When cooled compounds 7a-c were stirred with hydrazine hydrate in ethanol and then warmed to room temperature for 6h, they yielded 5-amino-4-iminopyrazolo[3,4-d]-pyrimidines (9a-c) in good yield. The proposed structures for the products 9a-c were supported by their elemental analysis and spectral data (see Experimental).
The imidates 7a-c gave 2-arylpyrazolo[3,4-d]-1,2,4-triazolo[5,1-f] pyrimidine systems (10-12) when reacted with 2-furancarboxylic acid hydrazide, 2-thiophenecarboxylic acid hydrazide and 4-pyridinecarboxylic acid hydrazide, respectively. The structures of the reaction products were assigned based on correct elemental analysis and spectral data (for example, the IR spectrum shows the absence of nitrile and amino bands, while the 1H-NMR spectrum shows the signals of hydrogen atoms respectively characteristic of the aryl moiety in 2-position).
Scheme 3.
Scheme 3.
Molecules 06 00621 g004
The pyrazole derivatives 3a-c undergo cyclization to afford several other new pyrazolo [3,4-d] pyrimidines (13-20) when reacted with formic acid, carbon disulfide, phenylisocyanate, phenylisothiocyanate, urea, thiourea and guanidine respectively. The structures of the synthesized compounds were established by elemental analysis and spectral data. (see Experimental).

Conclusions

We have presented various methods for synthesis of novel pyrazolo[3,4-d]pyrimidines with a pyridazine moiety at the1-position.

Experimental

General

Melting points were determined on a Reichert hot stage microscope and are uncorrected. IR spectra were measured with a Nicolet Magna 520 instrument, using potassium bromide and results are given in cm-1. 1H-, 13C NMR and 2D H-H, C-H, Cosy NMR spectra were recorded in DMSO-d6 on either a JEOL JNM-GX270, (1H-NMR at 270 MHz), (13C-NMR at 52.89MHz) or a Varian Gemini (1H-NMR at 200 MHz), (13C-NMR at 90.56 MHz ) spectrometer. The chemical shifts are reported in part per million (ppm) downfield from internal tetramethylsilane. Electron impact MS spectra were obtained on a JEOL JMS-HX 100 at 70 eV. Elemental microanalysis were done on a CARLO Erba analyzer model 110. The progress of all reactions was monitored by TLC on 2.0 cm x 6.0 cm aluminium sheets precoated with silica gel 60 containing a fluorescent indicator (Alugram SIL G/UV254 fur die DC Macherey-Nagel/ Germany), to a thickness of 0.25 mm. The developed chromatograms were viewed under ultraviolet light. Column chromatography was performed on [Merck] silica gel (70-230 mesh) (elution with 1:1 cyclohexane-ethyl acetate). The X-ray structure was determined using a NONIUS Kappa Diffractomer. Suitable crystals were grown by slow crystallization from ethanol.
General Procedure for the Preparation of 5-Amino-3-substituted-1-[6-(p-tolyl) pyridazin-3-yl]-pyrazole -4-carbonitriles (3a-c).
To a cold solution of hydrazine 2 (2.0g , 10 mmol) in methanol (100 mL) was added 1 (10 mmol). The reaction mixtures were then stirred at room temperature for 3-6h, left overnight, then the solvent was evaporated and the residue recrystallized from a suitable solvent.
5-Amino-3-methylthio-1-[6-(p-tolyl)pyridazin-3-yl]-pyrazole-4-carbonitrile (3a).
Yield: 89 %; colorless needle-like crystals; mp 259-260 °C (from EtOH); IR: ν max cm-1 3379, 3279 (NH2); 2210 (CN); 1H-NMR: δ: 2.41 (s, 3H, CH3-S), 2.60 (s, 3H, p-CH3-tolyl), 7.02 (bs, 2H, NH2, D2O exchangeable), 7.31 (d, 2H, H3, H5 – tolyl, J = 8.0 Hz), 7.90 (d, 2H, H2, H6- tolyl, J = 8.0 Hz), 8.13 (d, 1H, H5-pyridazine, J = 9.1 Hz), 8.36 (d, 1H, H4-pyridazine, J = 9.1 Hz); 13C-NMR: δ 15 (CH3-S), 20 (p-CH3-tolyl), 79 (CN), 134 (C-CN), 140 (C-SCH3), 113, 127, 129, 153 (C4,C3,C2 and C1 of tolyl); 118, 126, 154, 156 (pyridazine C5, C4, C6 and C3); 157 (C-NH2); MS m/z (%): M+ 322 (100), 275 (77), 250 (69), 115 (54), 78 (7.7); Anal. Calc. for C16H14N6S (322.39): C 59.61, H 4.38, N 26.07, S 9.94; Found: C 59.25, H 4.26, N 26.10, S 9.95.
Single-Crystal X-ray Structure Analysis of 3a: Crystallographic Data and Refinement.
Crystal Orthorhombic, space group P212121, a= 4.97330(10)Å, b= 11.1882(3)Å, c= 28.0997(8) Å.
CELL 4.97330 11.18820 28.09970 90.0000 90.0000 90.0000.
ZERR 4 0.00010 0.00029 0.00080 0.000 0.000 0.000.
LATT –1.
SYMM 0.5-X, -Y, 0.5+Z. SYMM 0.5+X, 0.5-Y, -Z. SYMM –X, 0.5+Y, 0.5-Z.
Volume 1563.53(7) Å3 .
Z, calculated density 4, 1.370 /m3.
Absorption coefficient 0.215 mm-1.
F(000) 672.
Theta range for data collection 1.96 to 27.49 deg.
Limiting indices –6<=h<=6, -14<=k<=14, -35<=1<=35.
Reflections collected/unique 3468/3468 [R(int) = 0.0000].
Refinement method full-matrix least-squares on F2.
Goodness-of-fit on F2 0.978.
Final R indices [I>2sigma(I)] R1 = 0.0498, wR2 = 0.1134.
R indices (all data) R1 = 0.1182, wR2 = 0.1374.
5-Amino-3-N-phenylamino-1-[6-(p-tolyl)pyridazin-3-yl]-pyrazole-4-carbonitrile (3b).
Yield: 70 %; white solid, mp 297 °C (from EtOH); IR: ν max cm-1 3461-3311 (NH2/NH); 2213 (CN); 1H-NMR δ: 2.45 (s, 3H, p-CH3-tolyl), 6.82 (bs, 2H, NH2, D2O exchangeable), 7.18 (t, 1H, H4-Ph, J = 7.4 Hz), 7.34 (t, 2H, H3, H5-Ph, J = 7.6 Hz), 8.21 (d, 2H, H2, H6-Ph, J = 7.9 Hz), 7.61 (d, 2H, H3, H5- tolyl, J = 8.0 Hz), 8.04 (d, 2H, H2, H6-tolyl, J = 8.0 Hz), 8.26 (d, 1H, H5–pyridazine, J = 9.1 Hz ), 8.42 (d, 1H, H4-pyridazine, J = 9.1 Hz), 9.22 (bs, 1H, NH, D2O exchangeable); MS: m/z (%); M+ 367 (75), 270 (100 ), 115 (42), 78 (8.1); Anal. Calc. for C21H17N7 (367.41): C 68.65, H 4.66, N 26.69; Found: C 68.49, H 4.68, N 26.70.
5-Amino-1-[6-(p-tolyl)pyridazin-3-yl]-pyrazole-3,4-dicarbonitrile (3c).
Yield: 86 %; pale brown solid; mp 289-292°C (from n-BuOH); IR: ν max cm-1 3369, 3282 (NH2); 2239, 3231(2CN); 1H-NMR δ: 2.43 (s, 3H, p-CH3-tolyl), 7.42 (d, 2H, H3, H5-tolyl, J = 8.0 Hz), 8.04 (d, 2H, H2, H6-tolyl, J = 8.0 Hz), 8.17 (d, 2H, H5-pyridazine, J = 9.1 Hz), 8.51 (d, 2H, H4-pyridazine, J = 9.1 Hz), 8.61 (bs, 2H, NH2, D2O exchangeable); MS: m/z (%); M+ 301(88), 275 (100 ), 78 (52), 65 (65); Anal. Calc. for C16 H11N7 (301.31): C 63.78, H 3.68, N 32.54; Found: C 64.02, H 3.68, N 32.39.
General Procedure for Preparation of 5-Methoxymethyleneamino-3-substituted-1-[6-(p-tolyl)-pyridazin-3-yl]-pyrazole-4-carbonitrilse (7a-c).
A mixture of pyrazole-o-aminonitriles 3a-c (10 mmol), triethylorthoformate (3mL) and acetic anhydride (3 mL) was refluxed for 6h. The solvent was removed under reduced pressure and the resulting solid was recrystalized from ethanol.
5-Methoxymethyleneamino-3-methylthio-1-[6-(p-tolyl)pyridazin-3-yl]-pyrazole-4-carbonitrile (7a).
Yield: 75 %; white solid, mp 132 °C ; IR ν max cm-1: 3380 (NH), 2920, 2827 (CH), 2218 (CN).
5-Methoxymethyleneamino-3-N-phenylamino-1-[6-(p-tolyl)pyridazin-3-yl]-pyrazole-4-yl-carbonitrile (7b).
Yield: 61 %; white solid, mp 230 °C IR: ν max cm-1: 3326 (NH), 2917, 2849 (CH), 2225 (CN)
5-Methoxymethyleneamino-1-[6-(p-tolyl)pyridazin-3-yl]-pyrazole-3,4-yl-dicarbonitrile (7c).
Yield: 66% yield; white solid, mp 209-210 °C; IR ν max cm-1: 3416 (NH), 2933, 2860 (CH), 2229, 2225 (2CN).
General procedure for the Preparation of 3-Substituted-1-[6-(p-tolyl)pyridazin-3-yl]-pyrazolo[3,4-d]pyrimidine-4-amines (8a-c).
Methanimidates 7a-c (3 mmol) were added to methanol (20 mL) saturated with ammonia at 0°C for 1h, warmed to room temperature and the reaction mixture stirred for 6h. The solid which precipitated was collected and recrystallized from an appropriate solvent.
3-Methylthio-1-[6-(p-tolyl)pyridazin-3-yl]pyrazolo[3,4-d]pyrimidine-4-amine (8a).
Yield: 81 %; pale yellow solid, mp 275 °C (from n-BuOH); IR ν max cm-1: 3410, 3362 (NH2); 1H-NMR δ: 2.46 (s, 3H, S-CH3), 2.60 (s, 3H, p-CH3-tolyl), 7.43 (d, 2H, H3,H5-tolyl, J = 8.0 Hz), 7.71 (bs, 2H, NH2, D2O exchangeable), 8.00 (d, 2H, H2,H6-tolyl, J = 8.0 Hz), 8.20 (d, 2H, H5-pyridazine, J = 9.1 Hz), 8.42 (d, 2H, H4-pyridazine, J = 9.1 Hz); 13C-NMR δ: 18 (S—CH3-tolyl), 20 (p-CH3-tolyl), 112, 118, 124, 128, 131, 133, 138, 151, 155, 156, 158, 159, 160 (aromatic); MS: m/z (%); M+ 349(100), 334(27), 274(94), 244 (49). Anal. Calc. for C17 H15N7S (349.41); C 58.44, H 4.33, N 28.06, S 9.18; Found : C 58.29, H 4.34, N 27.98, S 9.20.
3-N-Phenylamino-1-[6-(p-tolyl)pyridazin-3-yl]pyrazolo[3,4-d]pyrimidine-4-amine (8b).
Yield 34 %; light brown solid, mp 285-287 °C (from dioxane); IR ν max cm-1: 3370-3180 (NH2/NH); 1H-NMR δ: 2.52 (s, 3H, p-CH3-tolyl), 7.04 (t, 1H, H4-Ph, J = 7.4 Hz), 7.30 (t, 2H,H3,H5- Ph, J = 7.6 Hz), 7.41 (d, 2H, H3,H5- tolyl, J = 8.0 Hz), 7.85 (bs, 2H, NH2, D2O exchangeable), 7.90 (d, 2H, H2-Ph, H6-Ph, J = 7.9 Hz), 8.16 (d, 2H, H4. H6-tolyl, J = 8.0 Hz), 8.20 (d, 1H, H5-pyridazine, J = 9.1 Hz), 8.33 ( bs , 1H, NH, D2O exchangeable), 8.40 (d, 1H, H4-pyridazine, J = 9.1Hz), 8.64 (s, 1H, pyrimidine); 13C-NMR δ: 20 (p-CH3-tolyl), 114, 121, 122, 123, 124, 128, 130, 131, 133, 135, 138, 151, 155, 156, 158, 159, 160 (aromatic); MS: m/z (%); M+ 394(86), 378(52), 288(100), 244 (73), 77(15); Anal. Calc. for C22 H18N8 (394.44); C 66.99, H 4.60, N 28.41; Found : C 67.05, H 4.60, N 28.39.
Amino-1-[6-(p-tolyl)pyridazin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonitrile (8c).
Yield: 65 %; yellow crystals, mp >320 °C (from EtOH); IR ν max cm-1: 3397, 3276 (NH2), 2240 (CN); 1H-NMR δ: 2.45 (s, 3H, p-CH3-tolyl), 7.40 (d, 2H, H3, H5- tolyl, J = 8.0 Hz), 7.93 (bs, 2H, NH2, D2O exchangeable), 8.00 (d, 2H, , H2, H6-tolyl, J = 8.0 Hz), 8.12 (d, 1H, H5-pyridazine, J = 9.1 Hz), 8.51 (d, 1H, H4-pyridazine, J = 9.1Hz); MS m/z (%): M+ 328(95), 312(100), 302(44); Anal. Calc. for C17 H12N8 (328.34); C 62.19, H 3.68, N 34.13; Found: C 62.16, H 3.71, N 34.18.
General Procedure for the Preparation of 4-imino-3-substituted-1-[6-(p-tolyl)pyridazin-3-yl]-4,5-dihydropyrazolo[3,4-d]- pyrimidine-5-amines (9a-c).
To a well stirred cold solution of methanimidate 7a-c (20 mmol) in ethanol (10 mL), 99 % hydrazine hydrate (3 mL) was added over 2h, then the mixture was stirred at room temperature for 6h and left overnight. The solid that precipitated was filtered off and purified by passage though a column of silica gel with cyclohexane -ethyl acetate (1:1) as eluent.
4-Imino-3-methylthio-1-[6-(p-tolyl)pyridazin-3-yl]-4,5-dihydropyrazolo[3,4-d] pyrimidine-5-amine (9a).
Yield: 96 %; white solid, mp 238 °C; IR ν max cm-1: 3352-3204 (NH2/NH); 1H-NMR δ: 2.37 (s, 3H, S-CH3), 2.66 ( s, 3H, p-CH3-tolyl), 6.35 (bs, 2H, NH2, D2O exchangeable), 7.41 (d, 2H, H3, H5-tolyl, J = 8.0 Hz), 8.06 (d, 2H, H3, H5- tolyl, J = 8.0 Hz), 8.22 (d, 1H, H5-pyridazine, J = 9.1 Hz), 8.30 (bs, 1H, NH, D2O exchangeable), 8.41 (d, 1H, , H4-pyridazine, J = 9.1Hz) , 8.54 (s, 1H, pyrimidine); MS: m/z (%); M+ 364(95), 348(100), 317(33), 301 (58); Anal. Calc. for C17 H16N8S (364.43): C 56.03, H 4.43, N 30.75, S 8.80; Found: C 55.96, H 4.46, N 30.70, S 8.74.
4-Imino-3-N-phenylamino-1-[6-(p-tolyl)pyridazin-3-yl]-4,5-dihydropyrazolo[3,4-d]- pyrimidine-5-amine (9b).
Yield: 70 %; yellow solid, mp 279-281 °C; IRν max cm-1: 3458-3120, (NH2/2NH); 1H-NMR δ: 2.51 (s, 3H, p-CH3-tolyl), 6.91 (t, 1H, H4-Ph, J = 7.4 Hz), 7.23 (t, 2H, H3, H5-Ph, J = 7.6 Hz), 7.36 (d, 2H, H3, H5-tolyl, J = 8.0 Hz), 7.42 (bs, 2H, NH2, D2O exchangeable), 7.64 (d, 2H, H2, H6-Ph, J= 7.9 Hz), 8.00 (d, 1H, H2, H6-tolyl, J = 8.0 Hz), 8.10 (d, 1H, , H5-pyridazine, J = 9.1 Hz), 8.41 (d, 1H, H4-pyridazine, J = 9.1Hz), 8.55 (s, 1H, pyrimidine), 9.03 (bs, 1H, NH, D2O exchangeable); MS: m/z (%); M+ 409 (100), 394 (51), 288 (84). Anal. Calc. for C22 H19N9 (409.45): C 64.54, H 4.68, N 30.79; Found: C 64.18, H 4.67, N 31.01.
5-amino-4-imino-1-[6-(p-tolyl)pyridazin-3-yl]-4,5-dihydropyrazolo[3,4-d]pyrimidine-3-carbonitrile (9c).
Yield: 89 %; beige solid, mp 271-273 °C; IR ν max cm-1 3420-3230 (NH2, 2NH); 2236 (CN); 1H-NMR δ 2.42 (3H, s, p-CH3-tolyl), 7.33 (d, 2H, H3, H5-tolyl, J = 8.0 Hz), 7.65 (2H, bs, NH2, D2O exchangeable), 8.00 (d, 2H, H2, H6-tolyl, J = 8.0 Hz), 8.21 (d, 1H, H5-pyridazine, J = 9.1 Hz), 8.42 (d, 1H, H4-pyridazine, J = 9.1Hz), 8.77 (1H, bs, NH, D2O exchangeable); MS m/z (%): M+ 343 (100), 237 (66), 211 (87).Anal. Calc. for C17H13N9 (343.35): C 59.47; H 3.82 ; N 36.71; Found: C 59.47, H 3.84, N 36.70.
General procedure for the Preparation of 2-Aryl-9-substituted-7-[6-(p-tolyl) pyridazin-3-yl]-pyrazolo[3,4-d]-1,2,4-triazolo[5,1-f] pyrimidines (10-12).
Methanimidates 7a-c (20 mmol) were dissolved in dioxane (20 mL), and 2-furancarboxylic acid hydrazide, 2-thiophenecarboxylic acid hydrazide or 4-pyridinecarboxylic acid hydrazide (22 mmol) was added. The mixture was refluxed for 6-14 h, cooled, the solvent removed under reduced pressure and the resulting precipitate was purified by recrystallization or column chromatography.
2-(2-Furyl)-9-methylthio-7-[6-(p-tolyl)pyridazin-3-yl]-pyrazolo[3,4-d]-1,2,4-triazolo[5,1-f]-pyrimidine (10a).
Yield: 78 %; pale yellow solid, mp 215-216 °C (from DMF/H2O); IR ν max cm-1: 3096, 2919, 1628; 1H-NMR δ: 2.54 (s, 3H, S-CH3), 2.66 (s, 3H, p-CH3-tolyl), 6.81 (m, 1H, furyl), 7.42 (m, 2H + 1H, H-tolyl+ 1H-furyl), 7.65 (d, 2H, H3, H5- tolyl, J = 8.0 Hz), 7.87 (m, 1H, furyl), 8.01 (d, 1H, H5-pyridazine, J = 9.1 Hz), 8.32 (d, 1H, , H4-pyridazine, J = 9.1 Hz), 8.65 (s, 1H, pyrimidine); MS m/z (%): M+ 440 (95), 393 (100), 326 (39); Anal. Calc. for C22 H16N8SO (440.48): C 59.99, H 3.66, N 25.44, S 7.28; Found : C 59.85, H 3.61, N 25.40, S 7.29.
2-(2-Thienyl)-9-methylthio-7-[6-(p-tolyl)pyridazin-3-yl]-pyrazolo[3,4-d]-1,2,4-triazolo[5,1-f] pyrimidine (10b).
Yield: 47 %; beige solid, mp 247-249 °C (from DMF/ H2O); IR ν max cm-1: 3101, 2918, 1625; 1H-NMR δ: 2.53 (s, 3H, S-CH3), 2.64 ( s, 3H, p-CH3-tolyl), 7.21 (m, 1H, thienyl), 7.55 (m, 2H + 1H, H-tolyl+1H-thienyl), 7.76 (d, 2H, H3, H5- tolyl, J = 8.0 Hz), 7.87 (m, 1H, thienyl), 8.21 (d, 1H, H5- pyridazine, J = 9.1Hz), 8.43 (d,1H, H4-pyridazine, J = 9.1 Hz), 8.71 (s, 1H, pyrimidine); MS m/z (%):M+ 456 (95), 409 (100), 326 (57); Anal. Calc. for C22 H16N8S2 (456.55): C 57.88, H 3.53, N 24.54, S 14.04; Found : C 57.87, H 3.56, N 24.51, S 13.99.
2-(4-pyridyl)-9-methylthio-7-[6-(p-tolyl)pyridazin-3-yl]-pyrazolo[3,4-d]-1,2,4-triazolo[5,1-f]pyrimidine (10c).
Yield: 71 %; white solid, mp 240-243 °C [column chromatography, (5:1) cyclohexane/ethyl acetate]; IR ν max cm-1: 3084, 2926, 1627; 1H-NMR δ: 2.42 (s, 3H, S-CH3), 2.60 ( s, 3H, p-CH3-tolyl), 7.43 (d, 2H, H3, H5-tolyl, J = 8.0 Hz), 7.81 (d, 2H, pyridyl, J = 8.0 Hz), 8.10 (d, 2H, H2, H6-tolyl, J = 8.0 Hz), 8.46 (d, 1H, H5- pyridazine, J = 9.1 Hz ), 8.55 (d, 1H, H4-pyridazine, J = 9.1, Hz), 8.67 (s, 1H, pyrimidine), 8.71 (d, 2H, pyridyl J = 8.0 Hz); MS m/z (%): M+ 451 (68), 404 (100), 326 (51); Anal. Calc. for C23 H17N9S (451.51): C 61.18, H 3.79, N 27.92, S 7.10; Found : C 61.16, H 3.77, N 27.94, S 6.99.
2-(2-Furyl)-9-N-phenylamino-7-[6-(p-tolyl)pyridazin-3-yl]-pyrazolo[3,4-d]-1,2,4-triazolo-[5,1-f] pyrimidine (11a).
Yield: 64 %; white solid, mp 285 °C [column chromatography, (5:1) cyclohexane/ethyl acetate]; IR ν max cm-1: 3415, 3086, 2921, 1616; 1H-NMR δ: 2.50 ( s, 3H, p-CH3-tolyl), 6.82 (m, 1H, furyl), 6.90 (t, 1H, H4-Ph, J = 7.4 Hz), 7.27 (m, 2H + 2H+ 1H, H-tolyl + H-phenyl + H-furyl), 7.65 (d, 2H, H2, H6-tolyl, J = 8.0 Hz), 8.00 (m, 1H+ 2H, H-furyl, H-phenyl), 8.19 (d, 1H, H5-pyridazine, J = 9.1 Hz), 8.34 (d, 1H, H4-pyridazine, J = 9.1 Hz), 8.52 (s, 1H, pyrimidine); MS m/z (%): M+ 485 (93), 393 (100), 326 (69); Anal. Calc. for C27 H19N9O (485.50): C 66.80, H 3.94, N 25.96; Found : C 66.80, H 3.97, N 25.98.
2-(2-Thienyl)-9-N-phenylamino-7-[6-(p-tolyl)pyridazin-3-yl]-pyrazolo[3,4-d]-1,2,4-triazolo- [5,1-f] pyrimidine (11b).
Yield: 83 %; pale brown solid, mp >320 °C (from dioxane); IR ν max cm-1: 3413, 3110, 2921, 1607; 1H-NMR δ: 2.52 (s, 3H, p-CH3-tolyl), 6.91 (t, 1H, H4-Ph, J = 7.4 Hz), 7.15 (m, 1H, thienyl), 7.40 (m, 2H , H-tolyl+ H-phenyl+ 1H-thienyl), 7.69 (d, 2H, H2, H6- tolyl, J = 8.4 Hz), 7.82 (m, 1H, thienyl), 8.02 (m, 2H-phenyl,1H-pyridazine), 8.36 (d, 1H, H4-pyridazine), 8.50 (s, 1H, pyrimidine); MS m/z (%): M+ 501 (94), 418 (100), 326 (90); Anal. Calc. for C27 H19N9S (501.57): C 64.66, H 3.82, N 25.13, S 6.39; Found : C 64.66, H 3.80, N 25.09, S 6.36.
2-(4-Pyridyl)-9-N-phenylamino-7-[6-(p-tolyl)pyridazin-3-yl]-pyrazolo[3,4-d]-1,2,4-triazolo-[5,1-f] pyrimidine (11c).
Yield: 61 %; yellow flakes, mp >320 °C (from dioxane); IR ν max cm-1: 3375, 3095, 2921, 1599; 1H-NMR δ: 2.53 (d, 3H, p-CH3-tolyl), 7.08 (t, 1H, H4-Ph, J = 7.4 Hz), 7.30 (m, 2H+2H, H-toly+H-phenyl), 7.50 (d, 2H, pyridyl, J = 8.0 Hz), 7.82 (d, 2H, H2, H6-tolyl, J = 8.0 Hz), 8.06 (d, 2H, H2, H6- Ph, J = 7.9 Hz), 8.25 (d, 1H, H5-pyridazine, J = 9.1 Hz), 8.39 (d, 1H, H4-pyridazine, J = 9.1 Hz), 8.47 (s, 1H, pyrimidine), 8.70 (d, 2H, pyridyl J = 8.0Hz): MS m/z (%): M+ 496 (100), 404 (70), 418 (61); Anal. Calc. for C28 H20N10 (496.53); C 67.73, H 4.00, N 28.21; Found : C 67.79, H 4.06, N 28.26.
2-(2-Furyl)-7-[6-(p-tolyl)pyridazin-3-yl]-pyrazolo[3,4-d]-1,2,4-triazolo[5,1-f]pyrimidine-9-carbonitrile (12a).
Yield: 46 %; beige solid, mp 230 °C (from dioxane); IR ν max cm-1: 3089, 2918, 2229, 1633. 1H-NMR δ: 2.35 ( s, 3H, p-CH3-tolyl), 7.07 (m, 1H, furyl), 7.31 (m, 2H-tolyl+1H-furyl), 8.09 (d, 2H, H2, H6-tolyl, J = 8.0 Hz), 8.15 (m, 1H, furyl), 8.28 (d, 1H, H5-pyridazine, J = 9.1 Hz), 8.45 (d, 1H, H4-pyridazine, J = 9.1 Hz), 8.70 (s, 1H, pyrimidine); MS m/z (%): M+ 419 (100), 393 (60), 352 (45); Anal. Calc. for C22 H13N9O (419.41); C 63.00, H 3.12, N 30.06; Found : C 62.99, H 3.15, N 30.02.
2-(2-Thienyl)-7-[6-(p-tolyl)pyridazin-3-yl]-pyrazolo[3,4-d]-1,2,4-triazolo[5,1-f]pyrimidine-9-carbonitrile (12b).
Yield: 40 %; beige solid, mp 262 °C (from dioxane); IR ν max cm-1:3104, 2917, 2224, 1630; 1H-NMR δ: 2.35 ( s, 3H, p-CH3-tolyl), 7.38 (m, 1H, thienyl), 7.44 (d, 2H, H3, H5-tolyl, J = 8.0 Hz), 7.80 (m, 1H, H-thienyl), 7.92 (m, 1H, thienyl), 8.05 (d, 2H, H2, H6- tolyl, J = 8.0 Hz ), 8.15 (d, 1H, H5- pyridazine, J = 9.1 Hz), 8.45 (d, 2H, H4-pyridazine, J = 9.1 Hz), 8.70 (s, 1H, pyrimidine); MS m/z (%): M+ 435 (91), 409 (100), 352 (70); Anal. Calc. for C22H13N9S (435.47): C 60.68, H 3.01, N 28.95, S 7.36; Found : C 60.59, H 3.08, N 28.91, S 7.33.
2-(4-Pyridyl)-7-[6-(p-tolyl)pyridazin-3-yl]-pyrazolo[3,4-d]-1,2,4-triazolo[5,1-f]pyrimidine-9-carbonitrile (12c).
Yield: 70 %; pale brown crystals, mp 320 °C (from EtOH); IR ν max cm-1: 3090, 2933, 2228, 1635; 1H-NMR δ: 2.44 (d, 3H, p-CH3-tolyl), 7.31 (d, 2H, H3, H5-tolyl, J = 8.0 Hz), 7.72 (d, 2H, pyridyl, J = 8.0 Hz), 8.06 (d, 2H, H2, H6-tolyl, J = 8.4 Hz), 8.13(d, 1H, H5-pyridazine, , J = 9.1 Hz), 8.52 (d, 1H, H4-pyridazine, J = 9.1 Hz), 8.62 (s, 1H, pyrimidine), 8.75 (d, 2H, pyridyl J = 8.0 Hz); MS m/z (%): M+ 430 (100), 404 (78), 352 (60); Anal. Calc. for C23 H14N10 (430.43): C 64.18, H 3.28, N 32.54; Found : C 64.22, H 3.20, N 32.55.
General Procedure for the Preparation of 3-Substituted-1-[6-(p-tolyl)pyridazin-3-yl]-pyrazolo[3,4-d]pyrimidine-4(5H)-ones (13a-c).
Compound 3a-c (5 mmol) was added to formic acid (5 mL, 85%) and the mixture was refluxed for 6h. The solid that precipitated was collected and recrystallized.
3-Methylthio-1-[6-(p-tolyl)pyridazin-3-yl]-pyrazolo[3,4-d]pyrimidine-4(5H)-one (13a).
Yield: 62 %; colorless needle-like crystals, mp 244 °C (from EtOH); IR ν max cm-1: 3381 (NH), 1658 (CO); 1H-NMR δ: 2.44 (s, 3H, S-CH3), 2.60 (s, 3H, p-CH3-tolyl), 7.42 (d, 2H, H3, H5-tolyl, J = 8.0 Hz), 8.00 (d, 2H, H2, H6-tolyl, J = 8.0 Hz), 8.14 (d, 1H, H5-pyridazine, J = 9.1 Hz), 8.35 (d, 1H, H4-pyridazine, J = 9.1 Hz), 8.53 (s, 1H, pyrimidine), 11.16 (s, 1H, NH, D2O exchangable); 13C-NMR δ: 14 (S—CH3), 20 (p-CH3-tolyl), 114–158 (aromatic), 131 (C-S-CH3), 163 (CO, pyrimidine); MS m/z (%): M+ 350 (72), 323 (100), 275 (96), 129 (84); Anal. Calc. for C17 H14N6OS (350.39): C 58.27, H 4.03, N 23.98, S 9.15; Found: C 57.95, H 4.14, N 24.02, S 9.20.
3-N-Phenylamino-1-[6-(p-tolyl)pyridazin-3-yl]-pyrazolo[3,4-d]pyrimidine-4(5H)-one (13b).
Yield: 34 %; colorless needle-like crystals, mp>320 °C (from EtOH); IR ν max cm-1: 3337, 3265 (2NH), 1660 (CO); 1H-NMR δ: 2.60 (s, 3H, p-CH3-tolyl), 6.88 (t, 1H, H4-Ph, J = 7.4 Hz), 7.22 (d, 2H, H3, H5-tolyl, J = 8.0 Hz), 7.51 (t, 2H, H3, H5-Ph, J = 7.6 Hz) 8.01 (m, 2H+ 2H, H-tolyl + H-phenyl), 8.24 (d, 1H, H5-pyridazine, J = 9.1 Hz), 8.33 (s, 1H, NH, D2O exchangable) 8.48 (d, 1H, H4 – pyridazine, J = 9.1 Hz), 8.60 (s, 1H, pyrimidine), 11.09 (s, 1H, NH, D2O exchangable); 13C-NMR (DMSO) δ: 15 (p-CH3-tolyl), 117-158 (aromatic), 131 (C-S-CH3), 169 (CO pyrimidine); MS m/z (%): M+ 395 (100), 323 (85), 292 (75); Anal. Calc. for C22 H17N7O (395.42): C 66.83, H 4.33, N 24.80; Found: C 66.81, H 4.34, N 24.78.
4(5H)-Oxo-1-[6-(p-tolyl)pyridazin-3-yl]-pyrazolo[3,4-d]pyrimidine-3-carbonitrile (13c).
Yield: 55 %; colorless needle-like crystals, mp>320 °C (from dioxane); IR ν max cm-1: 3367 (NH), 1645 (CO); 1H-NMR δ: 2.63 (s, 3H, p-CH3-tolyl), 7.38 (d, 2H, H3, H5-tolyl, J = 8.0 Hz), 8.16 (d, 2H, H2, H6-tolyl, J = 8.0 Hz), 8.22 (d, 1H, H5- pyridazine, J = 9.1 Hz), 8.40 (d, 1H, H4-pyridazine, J = 8.0 Hz), 8.65 (s, 1H, pyrimidine), 12.50 (s, 1H, NH, D2O exchangable); 13C-NMR (DMSO) δ: 13 (p-CH3-tolyl), 84 (CN), (115–157 aromatic), (168, CO), pyrimidine]; MS m/z (%): M+ 329(90), 303(100), 271(81); Anal. Calc. for C17 H11N7O (329.39): C 62.00, H 3.37, N 29.77; Found: C 62.01, H 3.40, N 29.74.
General procedure for the Preparation of 3-Substituted-1-[6-(p-tolyl)pyridazin-3-yl]-pyrazolo-[3,4-d]pyrimidine-4,6(5H,7H)-dithiones (14a-c).
To a solution of 3a-c (10 mmol) in DMF (20 mL), carbon disulfide (10 mL,15 mmol) and 10 mL sodium methoxide (prepared from 0.59g of sodium metal and 30 mL methanol) were added. The mixture was refluxed for 15h, and then poured into ice cold water. A solution of sodium hydroxide (10 mL, 1M) was added to it and left overnight. The solution was filtered and acidified with dilute acetic acid to give a yellow precipitate. It was collected, washed with dilute acetic acid, dried and recrystallized from ethanol.
3-Methythio1-[6-(p-tolyl)pyridazin-3-yl]-pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dithione (14a).
Yield: 50 %; yellow needle crystals, mp 269°C; IR ν max cm-1: 3344, 3320 (2NH); 1H-NMR δ: 2.45 (s, 3H, S-CH3), 2.62 (s, 3H, p-CH3-tolyl), 7.50 (d, 2H, H3, H5-tolyl, J = 8.0 Hz), 8.14 (d, 2H, H2, H6-tolyl, J = 8.0 Hz), 8.21 (d, 1H, H5- pyridazine, J = 9.1 Hz), 8.52 (d, 1H, H4-pyridazine, J = 9.1 Hz), 8.70 (s, 1H, NH, D2O exchangable), 8.90 (s, 1H, NH, D2O exchangable); MS m/z (%): M+ 398 (72), 372 (100), 325 (96); Anal. Calc. for C17H14N6S3 (398.52): C 51.24, H 3.54, N 21.09, S 24.13; Found: 50.97, H 3.29, N 21.10, S 24.12.
3-N-Phenylamino-1-[6-(p-tolyl)pyridazin-3-yl]-pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dithione (14b).
Yield: 35 %; yellow solid, mp 260 °C; IR ν max cm-1: 3376 -3265 (3NH); 1H-NMR δ: 2.52 (s, 3H, p-CH3-tolyl), 6.90 (t, 1H, H4-Ph, J = 7.4 Hz), 7.16 (d, 2H, H3, H5-tolyl, J = 8.0 Hz), 7.52 (t, 2H, H3, H5- Ph, J = 7.6 Hz) 8.00 (m, 2H+ 2H, tolyl + H-phenyl), 8.14 (d, 1H, H5-pyridazine, J = 9.1 Hz), 8.36 (s, 1H, NH, D2O exchangable) 8.50 (d, 1H, H4-pyridazine, J = 9.1 Hz), 9.04 (s, 1H, NH, D2O exchangable), 9.77 (s, 1H, NH, D2O exchangable); MS m/z (%): M+ 443(100), 340(95), 308(81); Anal. Calc. for C22 H17N7S2 (443.54); C 59.58, H 3.86, N 22.11, S 14.46; Found: C 59.57, H 3.90, N 21.97, S 14.46.
1-[6-(p-tolyl)pyridazin-3-yl]-4,6-Dithioxo-4,5,6,7-tetrahydropyrazolo[3,4-d]pyrimidine-3-carbonitrile (14c).
Yield: 32 %; yellow solid, mp 239 °C; IR ν max cm-1: 3340- 3300 (2NH), 2220 (CN); 1H-NMR δ: 2.62 (s, 3H, p-CH3-tolyl), 7.10 (d, 2H, H3, H5- tolyl, J = 8.0 Hz), 7.81 (d, 2H, H2, H6-tolyl, J = 8.0 Hz), 8.06 (d, 1H, H5-pyridazine, J = 9.1 Hz), 8.42 (d, 1H, H4-pyridazine, J = 9.1 Hz), 9.27 (s, 1H, NH, D2O exchangable), 10.00 (s, 1H, NH, D2O exchangable); MS m/z (%): M+ 377 (100), 351 (98), 325 (75); Anal. Calc. for C17 H11N7S2 (377.44); C 54.10, H 2.94, N 25.98, S 16.99; Found: C 53.88, H 3.03, N 26.07, S 17.07.
General Procedure for the Preparation of 4-Imino-5-phenyl-3-substituted-1-[6-(p-tolyl)pyridazin-3-yl]-4,5-dihydropyrazolo[3,4-d]- pyrimidine-6(7H)-thiones/ones (15-17).
A mixture of 3a-c (10 mmol) and phenylisocyanate or phenylisothiocyanate (10 mmol) in pyridine (20 mL) was refluxed for 5h. The reaction mixture was cooled and poured onto ice/water and neutralized with diluted HCl. The solid product so formed was collected by filtration and recrystallized from ethanol.
4-Imino-5-phenyl-3-methylthio-1-[6-(p-tolyl)pyridazin-3-yl]-4,5-dihydropyrazolo[3,4-d]-pyrimidine-6(7H)-one (15a).
Yield: 90 %; white solid, mp 229 °C; IR ν max cm-1: 3395, 3326 (2NH), 1649 (CO); 1H-NMR δ: 2.44 (s, 3H, S-CH3), 2.56 (s, 3H, p-CH3-tolyl), 6.65 (t, 1H, phenyl, J = 6.6 Hz), 7.00 (d, 2H, H3, H5-tolyl, J = 8.0 Hz), 7.50 (m, 2H+ 2H, H-phenyl + H-tolyl), 7.81 (m, 2H + 2H, H-tolyl + H-phenyl), 8.06 (d, 1H, H5- pyridazine, J = 9.1Hz), 8.32 (d, 1H, H4-pyridazine, J = 9.1Hz), 8.80 (bs, 1H, NH, D2O exchangeable), 9.05 (bs, 1H, NH, D2O exchangeable); MS m/z (%): M+ 441 (90), 426 (100), 365 (42); Anal. Calc. for C23H19N7OS (441.50): C 62.57, H 4.34, N 22.21, S 7.26; Found: C 62.55, H 4.33, N 22.20, S 7.17.
4-Imino-5-phenyl-3-methylthio-1-[6-(p-tolyl)pyridazin-3-yl]-4,5-dihydropyrazolo-[3,4-d]-pyrimidine-6(7H)-thione (15b).
Yield: 79 %; beige solid, mp 275-276 °C; IR ν max cm-1: 3389-3279 (2NH); 1H-NMR δ: 2.36 (s, 3H, S-CH3), 2.60 (s, 3H, p-CH3-tolyl), 6.77 (t,1H,phenyl. J = 6.6 Hz), 7.00 (m, 2H, phenyl + tolyl), 7.44 (m, 2H+ 2H, phenyl + tolyl), 8.22 (d, 2H, H5-pyridazine, J = 9.1Hz), 8.42 (bs, 1H, NH, D2O exchangeable), 8.53 (d, 1H, H4-pyridazine, J = 9.1Hz), 9.33 (bs, 1H, NH, D2O exchangeable); MS m/z (%): M+ 457 (100), 365 (76), 318 (39); Anal. Calc. for C23H19N7S2 (457.57): C 60.37, H 4.19, N 21.43, S 14.01; Found: C 60.35, H 4.10,N 21.26, S 13.98.
4-Imino-5-phenyl-3-N-phenylamino-1-[6-(p-tolyl)pyridazin-3-yl]-4,5-dihydropyrazolo[3,4-d] pyrimidine-6(7H)-one (16a).
Yield: 44 %; white solid, mp 255 °C; IR ν max cm-1: 3380-3210(3NH), 1648 (CO); 1H-NMR δ: 2.51 (s, 3H, p-CH3-tolyl), 6.90-8.41 (m, 16H, aromatic), 8.55 (bs, 1H, NH, D2O exchangeable), 9.09 (bs, 1H, NH, D2O exchangeable), 11.08 (bs, 1H, NH, D2O exchangeable); MS m/z (%): M+ 486 (100), 394 (82), 317 (54); Anal. Calc. for C28 H22N8O (486.53): C 69.12, H 4.56, N 23.03; Found: C 69.12, H 4.57, N 23.02.
4-Imino-5-phenyl-3-N-phenylamino-1-[6-(p-tolyl)pyridazin-3-yl]-4,5-dihydropyrazolo[3,4-d]pyrimidine-6(7H)-thione (16b).
Yield: 46 %; beige solid, mp 306 °C; IR ν max cm-1: 3460-3298 (3NH); 1H-NMR δ: 2.45 (s, 3H, p-CH3-tolyl), 7.00-8.35 (m, 16H, aromatic), 8.60 (bs, 1H, NH, D2O exchangeable), 9.18 (bs, 1H, NH, D2O exchangeable), 11.13 (bs, 1H, NH, D2O exchangeable); MS m/z (%): M+ 502 (98), 410 (100), 333 (56); Anal. Calc. for C28H22N8S (502.60): C 66.91, H 4.41, N 22.29, S 6.38; Found: C 66.75, H 4.40, N 22.25, S 6.35.
4-Imino-5-phenyl-1-[6-(p-tolyl)pyridazin-3-yl]-4,5-dihydro-6(7H)-oxo-pyrazolo[3,4-d]-pyrimidine-3-carbonitrile (17a).
Yield: 43 %; beige solid, mp >320 °C; IR ν max cm-1: 3368-3307 (2NH), 2247 (CN); 1H-NMR δ: 2.42 (s, 3H, p-CH3-tolyl), 6.80 (t, 1H, phenyl, J = 6.6 Hz), 7.33-7.50 (m, 6H, phenyl + tolyl), 7.80 (d, 2H, H2, H6-tolyl, J = 8.0 Hz), 8.06 (d, 1H, H5-pyridazine, J= 9.1 Hz), 8.38 (d, 1H, H4-pyridazine, J = 9.1 Hz), 8.80 (bs, 1H, NH, D2O exchangeable), 11.07 (bs, 1H, NH, D2O exchangeable); MS m/z (%): M+ 420 (100), 394 (68), 333 (66); Anal. Calc. for C23H16N8O (420.43): C 65.71, H 3.84, N 26.65; Found: C 65.71, H 3.97, N 26.61.
4-Imino-5-phenyl-3-carbonitrile-1-[6-(p-tolyl)pyridazin-3-yl]-4,5-dihydropyrazolo-[3,4-d]-pyrimidine-6(7H)-thione (17b).
Yield: 42 %; yellow solid, mp >320 °C; IR ν max cm-1: 3343-3222 (2NH), 2247(CN); 1H-NMR δ: 2.44 (s, 3H, p-CH3-tolyl), 7.10 (t, 1H, phenyl, J = 6.6 Hz), 7.23-7.40 (m, 6H, phenyl + tolyl), 7.85 (d, 2H, H2, H6-tolyl, J = 8.0 Hz), 8.03 (d, 1H, pyridazine, J= 9.1 Hz), 8.36 (d, 1H, pyridazine, J = 9.1 Hz), 8.60 (bs, 1H, NH, D2O exchangeable), 11.13 (bs, 1H, NH, D2O exchangeable); MS m/z (%): M+ 436 (92), 369 (100), 353 (34); Anal. Calc. for C23H16N8S (436.49): C 63.29, H 3.69, N 25.67, S 7.34; Found: C 63.16, H 3.66, N 25.68, S 7.33.
General Procedure for the Preparation of 4-Amino-3-substituted-1-[6-(p-tolyl)pyridazin-3-yl]-pyrazolo[3,4-d]pyrimidine-6-ones/thiones/amines (18-20).
Compound 3a-c (5 mmol) and urea (10 mmol) or thiourea (10 mmol) or guanidine carbonate (5 mmol) were mixed in a mortar, The mixture was then heated at 180 °C in an oil bath for 20 minutes, heating was continued 2h, at the melting point of the pyrazole derivatives using reduced pressure. The molten product was boiled 10 minutes with water, cooled and filtered. The product was finally recrystallized from a suitable solvent.
Amino-3-methylthio-1-[6-(p-tolyl)pyridazin-3-yl]-pyrazolo[3,4-d]pyrimidine-6(7H)-one (18a).
Yield: 54 %; white solid, mp 275 °C (from dioxane); IR ν max cm-1: 3466-3206 (NH2/NH), 1685 (CO); 1H-NMR δ: 2.42 (s, 3H, S-CH3), 2.50 (s, 3H, p-CH3-tolyl), 7.35 (d, 2H, H3, H5-tolyl, J =8.0 Hz), 7.70 (d, 2H, H2,H6-tolyl, J = 8.0 Hz), 8.12 (bs, 2H, NH2, D2O exchangeable), 8.38 (d, 1H,H5-pyridazine, J = 9.1 Hz), 8.55 (d, 1H, H4-pyridazine, J = 9.1 Hz), 11.02, (bs, 1H, NH, D2O exchangeable); MS m/z (%): M+ 365 (100), 316 (87), 318 (56); Anal. Calc. for C17H15N7OS (365.41): C 55.88, H 4.14, N 26.83, S 8.77; Found: C 55.87, H 4.08,N 26.90, S 8.75.
4-Amino-3-methylthio-1-[6-(p-tolyl)pyridazin-3-yl]-pyrazolo[3,4-d]pyrimidine-6(7H)-thione (18b).
Yield: 63 %; yellow solid, mp >320 °C (from DMF/H2O); IR ν max cm-1: 3402-3180, (NH2/NH); 1H-NMR δ: 2.54 (s, 3H, S-CH3), 2.62 ( s, 3H, p-CH3-tolyl), 7.22 (d, 2H, H3, H5-tolyl, J = 8.0 Hz), 7.64 (d, 2H, H2, H6-tolyl, J = 8.0 Hz), 7.81 (bs, 2H, NH2, D2O exchangeable), 8.08 (d, 2H, H5-pyridazine), 8.54 (d, 1H, H4-pyridazine, J = 9.1Hz), 9.06 (bs, 1H, NH, D2O exchangeable); MS m/z (%): M+ 381 (93), 365 (100), 334 (39); Anal. Calc. for C17H15N7S2 (381.47): C 53.53, H 3.96, N 25.70, S 16.81; Found: C 53.53, H 4.02, N 25.70, S 16.79.
4,6-Diamino-3-methylthio-1-[6-(p-tolyl)pyridazin-3-yl]-pyrazolo[3,4-d]pyrimidine (18c).
Yield: 46 % yield; brown solid, mp 266 °C (from DMF/H2O); IR ν max cm-1: 3410-3254 (2NH2); 1H NMR δ: 2.53 (s, 3H, S-CH3), 2.60 (s, 3H, p-CH3-tolyl), 7.04 (d, 2H, H3, H5-tolyl, J = 8.0 Hz), 7.44 (d, 2H, H2, H6-tolyl, J = 8.0 Hz), 7.70 (bs, 2H, NH2, D2O exchangeable), 8.22 (d, 2H, H5-pyridazine, J = 9.1 Hz), 8.41 (bs, 1H, NH, D2O exchangeable), 8.66 (d, 1H, H4-pyridazine, J = 9.1 Hz),. MS: m/z (%); M+ 364(100), 348(56), 301(48); Anal. Calc. for C17 H16N8S (364.43): C 56.03, H 4.43, N 30.75, S 8.80; Found: C 56.00, H 4.41, N 30.72, S 8.79.
4-Amino-3-N-phenylamino-1-[6-(p-tolyl)pyridazin-3-yl]-pyrazolo[3,4-d]yrimidine-6(7H)-one (19a).
Yield: 43 %; white solid, mp 270 °C (from DMF/H2O); IR ν max cm-1: 3411-3160 (NH2/2NH), 1675 (CO); 1H-NMR δ: 2.53 (s, 3H, p-CH3-tolyl), 6.74(t, 1H,H4-phenyl, J = 7.4 Hz), 7.22 (m, 4H, H3, H5-phenyl+H3, H5-tolyl), 7.77 (t, 2H, H2, H6-phenyl, J = 7.9 Hz), 8.00(d, 2H, H2, H6-tolyl, J = 8.0 Hz), 8.15 (bs, 2H, NH2, D2O exchangeable), 8.33 (d, 1H, H5-pyridazine, J = 9.1 Hz), 8.54 (d, 2H, H4-pyridazine, J = 9.1 Hz), 12.36 (bs, 1H, NH, D2O exchangeable); MS m/z (%): M+ 410 (95), 394 (100), 318 (74); Anal. Calc. for C22 H18N8O (410.43): C 64.38, H 4.42, N 27.30; Found: C 64.36, H 4.46, N 27.30.
4-Amino-3-N-phenylamino-1-[6-(p-tolyl)pyridazin-3-yl]-pyrazolo[3,4-d]pyrimidine-6(7H)-thione (19b).
Yield: 44 % yield; yellow solid, mp 276 °C (from EtOH); IR ν max cm-1: 3411-3160 (NH2/2NH); 1H-NMR δ: 2.54 (s, 3H, p-CH3-tolyl), 6.90(t, 1H, H4- phenyl, J = 7.4 Hz), 7.20 (m, 4H, H3, H5-phenyl+ H3, H5-tolyl), 7.66 (m, 4H, H2, H6-phenyl +H2, H6-tolyl), 8.09 (bs, 2H, NH2, D2O exchangeable), 8.26 (d, 1H, H5-pyridazine, J = 9.1Hz), 8.40 (d, 1H, H4-pyridazine, J = 9.1 Hz), 11.45 (bs, 1H, NH, D2O exchangeable); MS m/z (%): M+ 426 (95), 334 (100), 318 (64); Anal. Calc. for C22H18N8S (426.50); C 61.96, H 4.25, N 26.27, S 7.52; Found: C 62.01, H 4.33, N 26.25, S 7.50.
4,6-Diamino-3-N-phenylamino-1-[6-(p-tolyl)pyridazin-3-yl]-pyrazolo[3,4-d]-pyrimidine (19c).
Yield: 52 %; yellow solid, mp>320 °C (from dioxane); IR ν max cm-1: 3397 -3110 (2NH2/NH); 1H-NMR δ: 2.61 (s, 3H, p-CH3-tolyl), 6.80 (t, 1H, H4-phenyl, J = 7.4 Hz), 7.22 (m, 4H, H3, H5-phenyl + H3, H5-tolyl), 7.45 (bs, 2H, NH2, D2O exchangeable) 7.60 (m, 4H, H2, H6 -phenyl + H2, H6-tolyl), 7.90 (bs, 2H, NH2, D2O exchangeable), 8.26 (d, 2H, H5-pyridazine, J = 9.1Hz), 8.50 (bs, 1H, NH, D2O exchangeable), 8.63 (d, 1H, H4”-pyridazine, J = 9.1Hz); MS m/z (%): M+ 409 (100), 317 (80), 301 (91); Anal. Calc. for C22H19N9 (409.45); C 64.54, H 4.68, N 30.79; Found: C 64.54, H 4.70, N 30.91.
4-Amino-3-carbonitrile-1-[6-(p-tolyl)pyridazin-3-yl]-pyrazolo[3,4-d]pyrimidine-6(7H)-one (20a).
Yield: 35 % yield; beige solid, mp >320 °C (from EtOH); IR ν max cm-1: 3421-3368 (NH2/NH), 2221 (CN), 1669 (CO); 1H-NMR δ: 2.50 (s, 3H, S-CH3), 2.63 (s, 3H, p-CH3-tolyl), 7.24 (d, 2H, H3, H5-tolyl, J = 8.0 Hz), 7.56 (d, 2H,H2, H6- tolyl, J = 8.0 Hz), 8.03 (bs, 2H, NH2, D2O exchangeable), 8.28 (d, 1H, H5-pyridazine, J = 9.1Hz), 8.40 (d, 1H, H4-pyridazine, J = 9.1Hz), 12.00 (bs, 1H, NH, D2O exchangeable); MS m/z (%): M+ 344 (95), 328 (100), 318 (62); Anal. Calc. for C17H12N8O (344.33): C 59.30, H 3.51, N 32.51; Found: C 59.29, H 3.46, N 32.50.
4-Amino-1-[6-(p-tolyl)pyridazin-3-yl]-pyrazolo[3,4-d]-6(7H)-thioxopyrimidine-3-carbonitrile (20b).
Yield: 38 %; yellow solid, mp 280 °C (from EtOH); IR ν max cm-1: 3399-3260 (NH2/NH), 2234 (CN); 1H-NMR δ: 2.45 (s, 3H, S-CH3), 2.61 (s, 3H, p-CH3-tolyl), 7.06 (d, 2H, H3, H5-tolyl, J = 8.0 Hz), 7.47 (d, 2H, H2, H6-tolyl, J = 8.0 Hz), 7.55 (bs, 2H, NH2, D2O exchangeable), 8.20 (d, 2H, H5-pyridazine, J = 9.1 Hz), 8.43 (d, 1H, H4-pyridazine, J = 9.1 Hz), 9.06 (bs, 1H, NH, D2O exchangeable); MS m/z (%): M+ 360 (92), 344 (100), 318 (39); Anal. Calc. for C17H12N8S (360.40): C 56.66, H 3.36, N 31.09, S 8.90; Found: C 56.90, H 3.42, N 30.99, S 8.79.
4,6-Diamino-3-carbonitrile-1-[6-(p-tolyl)pyridazin-3-yl]-pyrazolo[3,4-d] pyrimidine (20c).
Yield: 42 %; beige solid, mp >320 °C (from DMF/H2O); IR ν max cm-1: 3411-3270 (2 x NH2), 2218 (CN); 1H-NMR δ: 2.44 (s, 3H, S-CH3), 2.61 (s, 3H, p-CH3-tolyl), 7.38 (d, 2H, H3, H5-tolyl, J = 8.0 Hz), 7.53 (d, 2H, H2, H6-tolyl, J = 8.0 Hz), 8.05 (bs, 2H, NH2, D2O exchangeable), 8.22 (d, 1H, H5-pyridazine, J = 9.1Hz), 8.53 (d, 1H, H4-pyridazine, J = 9.1Hz), 8.64 (bs, 1H, NH, D2O exchangeable); MS m/z (%): M+ 343 (87), 311 (100), 285 (55); Anal. Calc. for C17H13N9 (343.35): C 59.47, H 3.82, N 36.71; Found: C 59.49, H 3.80, N 36.71.

Acknowledgments

The authors thank Dr. M. Fettouhi, King Fahad University of Petroleum and Minerals, for his efforts in facilitating the analysis of the X-ray analysis and the laboratory of Dr. Lahcene Ouahab, LCISM, UMR 6511, Rennes l University, France, for providing the X-ray structure analysis. The author extend their gratitude to the General Presidency for Girls Education for their partial financial support of this study.

References and Notes

  1. Petrie, C. R., III; Cottam, H.B.; McKernan, P.A.; Robins, R.K.; Revankar, G.R. Synthesis and biological activity of 6-azacadeguomycin and certain 3,4,6-trisubstituted pyrazolo[3,4-d] pyrimidine ribonucleosides. J. Med. Chem. 1985, 28, 1010–1016. [Google Scholar]
  2. Bhat, G. A.; Montero, J. G.; Panzica, R. P.; Worting, L.L.; Towsend, L. B. Pyrazolo-pyrimidine Nucleosides. 12. Synthesis and biological activity of certain pyrazolo[3,4-d]-pyrimidine nucleosides related to adenosine. J. Med.Chem. 1981, 24, 1165–1172. [Google Scholar] [CrossRef] [PubMed]
  3. Zacharie, B.; Connolly, T.P.; Rej, R.; Attardo, G.; Penney, C.L. A short synthesis of 4-substituted 1-(hydroxyalkyl)-1H-pyrazolo[3,4-d]pyrimidines. Tetrahedron 1996, 52, 2271–2278. [Google Scholar] [CrossRef]
  4. Anderson, J. D.; Cottam, H. B.; Larson, S. B.; Nord, L. D.; Revankar, G. R.; Robins, R. K. J. Heterocyclic Chem. 1990, 27, 439–453.
  5. Avila, J. L.; Polegre, M. A.; Avila, A. R.; Robins, K. Action of pyrazolopyrimidine derivatives on american Leiishmania SPP Promastigotes. Comp. Biochem. Physiol. 1986, 83C, 285–289. [Google Scholar]
  6. Contreras, J.; Rival, Y.; Chayer, S.; Bourguignon, J.; Wermuth, C. J. Med. Chem. 1999, 42, 730–741, and references therein.
  7. Al-Afaleq, E. I. Heterocyclic synthesis via enaminonitriles: An efficient, one step synthesis of some novel azolo[1,5-a]pyrimidine, pyrimido[1,2-a]benzimidazole, pyrido[1,2-a]benz-imidazole pyrimidine and pyrazole derivatives. Synth. Commun. 2000, 30, 1985–1999. [Google Scholar] [CrossRef]
  8. Jahine, H.; Sayed, A.; Zaher, H.A.; Sherif, O. Reactions of 3-chloro-& 3-hydrazino-6-(p-tolyl)pyridazines. Ind. J. Chem. 1977, 15B, 250–251. [Google Scholar]
  9. El-Shafei, Soliman, A.M.; Sultan, A.A.; El-Saghier, A.M. A Synthesis of some new hetero-cycles containing a bridghead nitrogen atom under PTC conditions. A new application of cyanoketene S,S-acetals. Gazz. Chim. Ital. 1995, 125, 115–118. [Google Scholar]
  10. S. M. Hecht, S.M.; Werner, D.; Traficante, D.D. Structure determination of the N-methyl isomers of 5-amino-3,4-dicyanopyrazole and certain Related pyrazolo[3,4-d]pyrimidines. J. Org. Chem. 1975, 40, 1815–1822. [Google Scholar] [CrossRef]
  • Sample availability: Not available

Share and Cite

MDPI and ACS Style

Al-Afaleq, E.I.; Abubshait, S.A. Heterocyclic o-Aminonitriles: Preparation of Pyrazolo[3,4-d]-pyrimidines with Modification of the Substituents at the 1- Position. Molecules 2001, 6, 621-638. https://doi.org/10.3390/60700621

AMA Style

Al-Afaleq EI, Abubshait SA. Heterocyclic o-Aminonitriles: Preparation of Pyrazolo[3,4-d]-pyrimidines with Modification of the Substituents at the 1- Position. Molecules. 2001; 6(7):621-638. https://doi.org/10.3390/60700621

Chicago/Turabian Style

Al-Afaleq, Eljazi I., and Samar A. Abubshait. 2001. "Heterocyclic o-Aminonitriles: Preparation of Pyrazolo[3,4-d]-pyrimidines with Modification of the Substituents at the 1- Position" Molecules 6, no. 7: 621-638. https://doi.org/10.3390/60700621

Article Metrics

Back to TopTop